Key result
The three-month incidence of venous thromboembolic disease was 2.27% following primary hip arthroplasty and 1.79% following total knee arthroplasty, with no change over a ten-year period.
Observational
Yes
Answers are grounded in this paper and cite their sources.
The incidence of VTE after hip and knee arthroplasty remained stable over a ten-year period despite increased prophylaxis, supporting the continuation of prophylaxis for at least six weeks post-surgery.
This population-based study investigated the incidence and trends in venous thromboembolic disease after total hip and knee arthroplasty over a ten-year period. Death or readmission for venous thromboembolic disease up to two years after surgery for all patients in Scotland was the primary outcome. The incidence of venous thromboembolic disease, including fatal pulmonary embolism, three months after surgery was 2.27% for primary hip arthroplasty and 1.79% for total knee arthroplasty. The incidence of fatal pulmonary embolism within three months was 0.22% for total hip arthroplasty and 0.15% for total knee arthroplasty. The majority of events occurred after hospital discharge, with no apparent trend over the period. The data support current advice that prophylaxis should be continued for at least six weeks following surgery. Despite the increased use of policies for prophylaxis and earlier mobilisation, there has been no change in the incidence of venous thromboembolic disease.
No takes yet. Share an insight, caveat, or question.
Howie et al. (2005) conducted an observational in Total hip and knee arthroplasty. Total hip and knee arthroplasty was evaluated on Death or readmission for venous thromboembolic disease up to two years after surgery. The three-month incidence of venous thromboembolic disease was 2.27% following primary hip arthroplasty and 1.79% following total knee arthroplasty, with no change over a ten-year period.
Synapse has enriched 10 related papers. Consider them for comparative context: